Dr. Debora Gagneten, M.D

NPI: 1992817100
Total Payments
$204,031
2024 Payments
$74,717
Companies
1
Transactions
16
Medicare Patients
859
Medicare Billing
$61,400

Payment Breakdown by Category

Consulting$204,031 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $204,031 16 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $204,031 16 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $74,717 4 AstraZeneca Pharmaceuticals LP ($74,717)
2023 $41,339 4 AstraZeneca Pharmaceuticals LP ($41,339)
2022 $54,225 4 AstraZeneca Pharmaceuticals LP ($54,225)
2021 $9,225 1 AstraZeneca Pharmaceuticals LP ($9,225)
2020 $24,525 3 AstraZeneca Pharmaceuticals LP ($24,525)

All Payment Transactions

16 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/31/2024 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $28,216.72 General
09/30/2024 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $13,445.76 General
06/30/2024 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $23,810.20 General
03/31/2024 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $9,243.96 General
12/31/2023 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $12,745.46 General
09/30/2023 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $9,243.96 General
06/30/2023 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $11,475.00 General
03/31/2023 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $7,875.00 General
12/31/2022 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $8,775.00 General
09/30/2022 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $10,350.00 General
06/30/2022 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $23,625.00 General
03/31/2022 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $11,475.00 General
12/31/2021 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $9,225.00 General
08/06/2020 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $12,825.00 General
07/03/2020 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $6,750.00 General
06/11/2020 AstraZeneca Pharmaceuticals LP Consulting Fee Cash or cash equivalent $4,950.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 91 181 $34,533 $5,976
2022 7 194 341 $73,327 $14,027
2021 8 272 543 $116,704 $21,647
2020 9 302 514 $101,598 $19,750
Total Patients
859
Total Services
1,579
Medicare Billing
$61,400
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88307 Pathology examination of tissue using a microscope, moderately high complexity Office 2023 14 38 $12,665 $2,427 19.2%
88341 Special stained specimen slides to examine tissue, each additional procedure Office 2023 11 68 $4,896 $1,557 31.8%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2023 36 45 $12,128 $1,355 11.2%
88342 Special stained specimen slides to examine tissue, initial procedure Office 2023 19 19 $2,884 $535.23 18.6%
88304 Pathology examination of tissue using a microscope, moderately low complexity Office 2023 11 11 $1,960 $101.53 5.2%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2022 30 59 $19,665 $4,233 21.5%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2022 56 87 $23,447 $2,854 12.2%
88309 Pathology examination of tissue using a microscope, high complexity Facility 2022 18 19 $9,259 $2,428 26.2%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2022 19 97 $6,984 $2,385 34.1%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2022 36 37 $5,617 $1,124 20.0%
88331 Pathology examination of specimen during surgery, first tissue block Facility 2022 12 13 $3,189 $712.13 22.3%
88304 Pathology examination of tissue using a microscope, moderately low complexity Facility 2022 23 29 $5,168 $291.56 5.6%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2021 45 99 $32,997 $7,370 22.3%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2021 84 179 $48,241 $5,927 12.3%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2021 28 130 $9,360 $3,310 35.4%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2021 52 58 $8,804 $1,815 20.6%
88309 Pathology examination of tissue using a microscope, high complexity Facility 2021 11 11 $5,360 $1,442 26.9%
88331 Pathology examination of specimen during surgery, first tissue block Facility 2021 17 24 $5,887 $1,338 22.7%
88304 Pathology examination of tissue using a microscope, moderately low complexity Facility 2021 24 29 $5,168 $298.40 5.8%
88311 Preparation of tissue for examination by removing any calcium present Facility 2021 11 13 $886.60 $145.84 16.4%
88307 Pathology examination of tissue using a microscope, moderately high complexity Facility 2020 45 75 $24,998 $5,719 22.9%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2020 81 131 $35,305 $4,520 12.8%
88341 Special stained specimen slides to examine tissue Facility 2020 31 144 $10,368 $3,746 36.1%
88309 Pathology examination of tissue using a microscope, high complexity Facility 2020 16 17 $8,284 $2,294 27.7%
88342 Tissue or cell analysis by immunologic technique Facility 2020 50 54 $8,197 $1,748 21.3%

About Dr. Debora Gagneten, M.D

Dr. Debora Gagneten, M.D is a Specialist healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992817100.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debora Gagneten, M.D has received a total of $204,031 in payments from pharmaceutical and medical device companies, with $74,717 received in 2024. These payments were reported across 16 transactions from 1 company. The most common payment nature is "Consulting Fee" ($204,031).

As a Medicare-enrolled provider, Gagneten has provided services to 859 Medicare beneficiaries, totaling 1,579 services with total Medicare billing of $61,400. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Anatomic Pathology
  • Location Silver Spring, MD
  • Active Since 09/01/2006
  • Last Updated 11/06/2019
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1992817100

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Silver Spring